Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

References
1 Burnet FM. The concept of immunological
surveillance. Prog Exp Tumor Res
1970; 13: 1±27.
2 Shankaran V, Ikeda H, Bruce AT,
White JM, Swanson PE, Old LJ,
Schreiber RD. IFN-g and lymphocytes
prevent primary tumour development
and shape tumour immunogenicity.
Nature 2001; 410: 1107±1111.
3 Vogelstein B, Kinzler KW. The multistep
nature of cancer. Trends Genet
1993; 9: 138±141.
4 Boon T, van der Bruggen P. Human
tumor antigens recognized by T lymphocytes.
J Exp Med 1996; 183: 725±
729.
5 Rosenberg SA. Progress in human tumour
immunology and immunotherapy.
Nature 2001; 411: 380±384.
6 Steinman RM, Turley S, Mellman I,
Inaba K. The induction of tolerance by
dendritic cells that have captured apoptotic
cells [Comment]. J Exp Med 2000;
191: 411±416.
7 Barnhill RL. Malignant melanoma ±
pathology and prognostic factors. Curr
Opin Oncol 1993; 5: 364±376.
8 Speiser DE, Miranda R, Zakarian A,
Bachmann MF, McKall-Faienza K,
Odermatt B, Hanahan D, Zinkernagel
R, Ohashi PS. Self antigens expressed
by solid tumors do not efficiently
stimulate naive or activated
T cells: implications for immunotherapy.
J Exp Med 1997; 186: 645±653.
9 Melcher AA, Gough MJ, Todryk S,
Vile RG. Apoptosis or necrosis for tumour
immunotherapy ± what's in a
name? J Mol Med 1999; 77: 824±833.
10 Gorelik L, Flavell RA. Immunemediated
eradication of tumors
through the blockade of transforming
growth factor-b signaling in T cells. Nat
Med 2001; 7: 1118±1122.
11 Anderson CC, Matzinger P. Immunity
or tolerance: opposite outcomes of
microchimerism from skin grafts. Nat
Med 2001; 7: 80±87.
12 Banchereau J, Steinman RM. Dendritic
cells and the control of immunity.
Nature 1998; 392: 245±252.
References
13 Allison JP, Krummel MF. The Yin
and Yan of T cell costimulation. Science
1995; 270: 932±933.
14 van Elsas A, Hurwitz AA, Allison JP.
Combination immunotherapy of B16
melanoma using anti-cytotoxic T lymphocyte-associated
antigen 4 (CTLA-4)
and granulocyte/macrophage colonystimulating
factor (GM-CSF)-producing
vaccines induces rejection of subcutaneous
and metastatic tumors accompanied
by autoimmune depigmentation.
J Exp Med 1999; 190: 355±366.
15 Marrack P, Kappler J, Kotzin BL.
Autoimmune disease: why and where it
occurs. Nat Med 2001; 7: 899±905.
16 Steinman L. Multiple sclerosis: a coordinated
immunological attack against
myelin in the central nervous system.
Cell 1996; 85: 299±302.
17 Wong FS,Visintin I,Wen L, Flavell
RA, Janeway CA Jr. CD8 T cell
clones from young nonobese diabetic
(NOD) islets can transfer rapid onset of
diabetes in NOD mice in the absence of
CD4 cells. J Exp Med 1996; 183: 67±76.
18 Kotzin BL. Systemic lupus erythematosus.
Cell 1996; 85: 303±306.
19 Bell JI, Lathrop GM. Multiple loci for
multiple sclerosis. Nat Genet 1996; 13:
377±378.
20 Poltorak A, Smirnova I, He X,
Liu MY,Van Huffel C, McNally O,
Birdwell D, Alejos E, Silva M, Du X,
Thompson P, Chan EK, Ledesma J,
Roe B, Clifton S,Vogel SN, Beutler
B. Genetic and physical mapping of
the Lps locus: identification of the Toll-
4 receptor as a candidate gene in the
critical region. Blood Cells Mol Dis 1998;
24: 340±355.
21 Seko Y, Takahashi N, Azuma M,Yagita
H, Okumura K,Yazaki Y. Expression
of costimulatory molecule CD40 in
murine heart with acute myocarditis
and reduction of inflammation by treatment
with anti-CD40L/B7±1 monoclonal
antibodies. Circ Res 1998; 83: 463±
469.
22 Quayle AJ,Wilson KB, Li SG, Kjeldsen-Kragh
J, Oftung F, Shinnick T,
225